PHIO Company Profile and Key Details

Q: Who are the executives of PHIO?

Ms. Linda M. MahoneySenior Vice President of Devel.Ms. Caitlin KontulisVice President of Fin. & Admin. and Sec.Mr. Robert J. BittermanPres, Chief Executive Officer & Chairman

NASDAQ : PHIO

Phio Pharmaceuticals

$1.14

0.24+26.67%

At Close 4:00 PM

56.64

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Phio Pharmaceuticals Corp. (PHIO) stock surged +24.44%, trading at $1.12 on NASDAQ, up from the previous close of $0.90. The stock opened at $1.40, fluctuating between $1.12 and $1.48 in the recent session.

Stock Snapshot

0.9

Prev. Close

12.06M

Market Cap

1.12

Day Low

-0.52

P/E Ratio

-2.15

EPS (TTM)

-2.87

Cash Flow per Share

1.4

Open

10.76M

Number of Shares

1.48

Day High

98.46%

Free Float in %

2.06

Book Value

161.16M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 10, 2026	1.41	1.48	1.12	1.12	161.29M
Feb 09, 2026	0.93	0.93	0.88	0.90	98.91K
Feb 06, 2026	0.84	0.93	0.84	0.92	123.53K
Feb 05, 2026	0.91	0.92	0.81	0.86	421.88K
Feb 04, 2026	0.98	0.98	0.91	0.93	317.18K
Feb 03, 2026	0.98	1.00	0.94	0.98	154.88K
Feb 02, 2026	1.00	1.01	0.97	0.99	275.28K
Jan 30, 2026	1.02	1.02	1.00	1.01	238.25K
Jan 29, 2026	1.03	1.03	1.00	1.02	183.84K
Jan 28, 2026	1.04	1.05	1.01	1.02	125.63K
Jan 27, 2026	1.03	1.06	1.01	1.03	218.95K
Jan 26, 2026	1.09	1.09	1.03	1.04	185.17K
Jan 23, 2026	1.09	1.09	1.05	1.09	198.07K
Jan 22, 2026	1.06	1.10	1.05	1.08	305.87K
Jan 21, 2026	1.06	1.07	1.01	1.04	379.82K
Jan 20, 2026	1.10	1.22	1.01	1.08	1.34M
Jan 16, 2026	1.14	1.15	1.11	1.14	132.14K
Jan 15, 2026	1.14	1.14	1.09	1.13	135.68K
Jan 14, 2026	1.17	1.17	1.12	1.12	224.73K
Jan 13, 2026	1.18	1.18	1.14	1.18	110.2K

Contact Details

Marlborough, MA 01752

United States

https://www.phiopharma.com 508 767 3861

About Company

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy in adoptive cell transfer (ACT); PH-894 that silences the epigenetic protein BRD4, which is an intracellular regulator of gene expression for use in ACT; and PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for use in ACT. It has collaborations with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.

Stock Peers

ARGX

4.92002+0.59%

argenx SE$833.16 REGN

-25.37-3.25%

Regeneron Pharmaceuticals, Inc.$754.91 MDGL

-9.43-1.93%

Madrigal Pharmaceuticals, Inc.$478.83 UTHR

0.08+0.02%

United Therapeutics Corporation$473.20 VRTX

-7.39-1.57%

Vertex Pharmaceuticals Incorporated$463.48 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

2.98+0.93%

Alnylam Pharmaceuticals, Inc.$322.98 PRAX

0.94+0.29%

Praxis Precision Medicines, Inc.$320.48 KRYS

-1.91-0.70%

Krystal Biotech, Inc.$270.70 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Phio Pharmaceuticals Corp. (PHIO) stock price?

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) stock price is $1.12 in the last trading session. During the trading session, PHIO stock reached the peak price of $1.48 while $1.12 was the lowest point it dropped to. The percentage change in PHIO stock occurred in the recent session was 24.44% while the dollar amount for the price change in PHIO stock was $0.22.

PHIO's industry and sector of operation?

The NASDAQ listed PHIO is part of Biotechnology industry that operates in the broader Healthcare sector. Phio Pharmaceuticals Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PHIO?

Ms. Linda M. Mahoney
Senior Vice President of Devel.
Ms. Caitlin Kontulis
Vice President of Fin. & Admin. and Sec.
Mr. Robert J. Bitterman
Pres, Chief Executive Officer & Chairman

How PHIO did perform over past 52-week?

PHIO's closing price is 40.22% higher than its 52-week low of $0.81 where as its distance from 52-week high of $4.19 is -72.79%.

How many employees does PHIO have?

Number of PHIO employees currently stands at 5.

Link for PHIO official website?

Official Website of PHIO is: https://www.phiopharma.com

How do I contact PHIO?

PHIO could be contacted at phone 508 767 3861 and can also be accessed through its website. PHIO operates from 257 Simarano Drive, Marlborough, MA 01752, United States.

How many shares of PHIO are traded daily?

PHIO stock volume for the day was 161.16M shares. The average number of PHIO shares traded daily for last 3 months was 375.73K.

What is the market cap of PHIO currently?

The market value of PHIO currently stands at $12.06M with its latest stock price at $1.12 and 10.76M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	5
Beta	0.94
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	5
Beta	0.94
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

PHIO Company Profile and Key Details

Phio Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook